Matches in Nanopublications for { ?s ?p "[In conclusion, the combination of myeloid growth factors and an (FcalphaRI x CD20) BsAb may represent a promising approach to improve effector cell recruitment for CD20-directed lymphoma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[In conclusion, the combination of myeloid growth factors and an (FcalphaRI x CD20) BsAb may represent a promising approach to improve effector cell recruitment for CD20-directed lymphoma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[In conclusion, the combination of myeloid growth factors and an (FcalphaRI x CD20) BsAb may represent a promising approach to improve effector cell recruitment for CD20-directed lymphoma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_assertion description "[In conclusion, the combination of myeloid growth factors and an (FcalphaRI x CD20) BsAb may represent a promising approach to improve effector cell recruitment for CD20-directed lymphoma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299758.RAB1RQOUYPvPRcOcsM9dWZDvpQ2ezzR8sANABHw8lPcXY130_provenance.
- NP299757.RAW8pY5kRBeUEptdo2OcXLpKizVX8DL8dGZJB_at-RvD8130_assertion description "[In conclusion, the combination of myeloid growth factors and an (FcalphaRI x CD20) BsAb may represent a promising approach to improve effector cell recruitment for CD20-directed lymphoma therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299757.RAW8pY5kRBeUEptdo2OcXLpKizVX8DL8dGZJB_at-RvD8130_provenance.